Specific Susceptibility to COVID-19 in Adults with Down Syndrome
-
Published:2021-03-04
Issue:4
Volume:23
Page:561-571
-
ISSN:1535-1084
-
Container-title:NeuroMolecular Medicine
-
language:en
-
Short-container-title:Neuromol Med
Author:
Illouz Tomer, Biragyn Arya, Frenkel-Morgenstern Milana, Weissberg Orly, Gorohovski Alessandro, Merzon Eugene, Green Ilan, Iulita Florencia, Flores-Aguilar Lisi, Dierssen Mara, De Toma Ilario, Lifshitz Hefziba, Antonarakis Stylianos E., Yu Eugene, Herault Yann, Potier Marie-Claude, Botté Alexandra, Roper Randall, Sredni Benjamin, Sarid Ronit, London Jacqueline, Mobley William, Strydom Andre, Okun EitanORCID
Abstract
AbstractThe current SARS-CoV-2 outbreak, which causes COVID-19, is particularly devastating for individuals with chronic medical conditions, in particular those with Down Syndrome (DS) who often exhibit a higher prevalence of respiratory tract infections, immune dysregulation and potential complications. The incidence of Alzheimer’s disease (AD) is much higher in DS than in the general population, possibly increasing further the risk of COVID-19 infection and its complications. Here we provide a biological overview with regard to specific susceptibility of individuals with DS to SARS-CoV-2 infection as well as data from a recent survey on the prevalence of COVID-19 among them. We see an urgent need to protect people with DS, especially those with AD, from COVID-19 and future pandemics and focus on developing protective measures, which also include interventions by health systems worldwide for reducing the negative social effects of long-term isolation and increased periods of hospitalization.
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology,Molecular Medicine
Reference64 articles.
1. Alsahabi, I., Alobaidi, A., Alahmari, A. S., Almohsen, N., & Alhamoud, A. H. (2021). Clinical Presentation and Successful Management of an Infant With Down Syndrome and COVID-19 in Riyadh Saudi Arabia. Cureus, 13(2), e13188. https://doi.org/10.7759/cureus.13188 2. Alsaied, T., Aboulhosn, J. A., Cotts, T. B., Daniels, C. J., Etheridge, S. P., Feltes, T. F., et al. (2020). Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease. J Am Heart Assoc, 9(12), e017224. https://doi.org/10.1161/JAHA.120.017224 3. Altable, M., & de la Serna, J. M. (2021). Down’s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach. Neurological Sciences, 42(2), 407–413. https://doi.org/10.1007/s10072-020-04880-x 4. Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., et al. (2020). Down syndrome. Nat Rev Dis Primers, 6(1), 9. https://doi.org/10.1038/s41572-019-0143 5. Avery, D. T., Deenick, E. K., Ma, C. S., Suryani, S., Simpson, N., Chew, G. Y., et al. (2010). B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. Journal of Experimental Medicine, 207(1), 155–155.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|